Brokers have been very busy in recent weeks working through updates and results.
This has led to countless recommendations being made in regard to which shares investors should buy or sell now.
Two dividend shares that have done enough to impress brokers are listed below. Here's why they have been given the thumbs up by analysts:
Image source: Getty Images
Australia and New Zealand Banking Group (ASX: ANZ)
According to a note out of Citi, its analysts believe this banking giant's shares are great value at the current level.
Citi currently has a buy rating and $29.00 price target on the bank's shares.
The broker sees positives from ANZ's plan to acquire the banking operations of Suncorp Group Ltd (ASX: SUN). It highlights that the deal meets a strategic objective and is being undertaken at a reasonable purchase price.
As for dividends, Citi is forecasting fully franked dividends per share of 144 cents in FY 2022 and then 165 cents in FY 2023. Based on the current ANZ share price of $22.64, this implies yields of 5.7% and 6.6%, respectively, over the next two years.
Healthco Healthcare and Wellness REIT (ASX: HCW)
A note out of Goldman Sachs reveals that its analysts are bullish on the Healthco Healthcare and Wellness REIT. It is a real estate investment trust with a focus on hospitals, aged care, childcare, life sciences, and primary care properties.
Goldman currently has a conviction buy rating and $2.08 price target on its shares.
Its analysts rate the REIT highly due to its robust balance sheet, favourable tenant mix, the resilience of healthcare and childcare assets, the expected strong future demand for assets across the care spectrum, and its attractive valuation.
In addition, the broker is forecasting good yields from Healthco Healthcare and Wellness. It expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.78, this will mean yields of 4.2% for investors.
